May 11, 2022 at 11:00am Eastern Time
At the end of the webinar, participants will be able to:
- Explain the underlying significance of the Ki67 cell proliferation protein
- Identify and critique the principal methods of IHC assessment of Ki67 in human tumors
- Illustrate newer approaches to improve accuracy and reproducibility of Ki67 assessment in human tumors
- Update the role of Ki67 assessment for selection of adjuvant abemaciclib treatment in breast cancer